Onderneming Eurofins Scientific SE Deutsche Boerse AG
Aandelen
ESF
FR0000038259
Gezondheidszorgvoorzieningen & -diensten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
53,62 EUR | -1,07% | -4,59% | -9,73% |
Vakgebied
Eind 2023 bezat Eurofins Scientific SE een portefeuille van meer dan 200.000 analysemethodes en beschikte wereldwijd meer dan 900 laboratoria.
De geografische verdeling van de omzet is als volgt: Europa (50,7%), Noord-Amerika (38,5%) en andere (10,8%).
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Sample-based
82,7
%
| 5 588 | 83,3 % | 5 388 | 82,7 % | -3,59% |
Study-based
8,3
%
| 572 | 8,5 % | 541 | 8,3 % | -5,37% |
Full Time Equivalent-based
6,9
%
| 426 | 6,4 % | 449 | 6,9 % | +5,28% |
Product-based
2,1
%
| 126 | 1,9 % | 137 | 2,1 % | +8,73% |
Other
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | +100,00% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe
50,8
%
| 3 507 | 52,2 % | 3 306 | 50,8 % | -5,72% |
North America
38,5
%
| 2 494 | 37,2 % | 2 507 | 38,5 % | +0,52% |
Rest of the World
10,8
%
| 711 | 10,6 % | 701 | 10,8 % | -1,38% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 01-01-87 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01-01-15 |
Christian Wurst
COO | Chief Operating Officer | - | 01-10-19 |
Yves-Loïc Martin
BRD | Director/Board Member | 58 | 01-01-92 |
François Vigneau
PRN | Corporate Officer/Principal | 58 | 01-11-96 |
Corporate Officer/Principal | 41 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 01-01-87 |
Yves-Loïc Martin
BRD | Director/Board Member | 58 | 01-01-92 |
Valérie Hanote
BRD | Director/Board Member | 58 | 01-01-91 |
Director/Board Member | 60 | 20-04-17 | |
Evie Roos
BRD | Director/Board Member | 57 | - |
Pascal Rakovsky
BRD | Director/Board Member | 65 | 01-06-20 |
Ivo Rauh
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 192 981 183 | 128 871 845 ( 66,78 %) | 955 858 ( 0,4953 %) | 66,78 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
EUROFINS CEREP 95.76% | 4 831 | 95.76% | 114 943 260 $ |
EUROFINS SCIENTIFIC SE 0.50% | 955 858 | 0.50% | 47 687 717 $ |
VIMTA LABS LIMITED 19.86% | 4 403 668 | 19.86% | 25 224 563 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Eurofins GeneScan Holding GmbH
Eurofins GeneScan Holding GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins GeneScan Holding GmbH is a world leader in food, environment, pharma product testing & agroscience CRO services. The company is based in Freiburg im Breisgau, Germany. The German company has a network of more than 1,000 independent companies (900 laboratories) in 61 countries, offering over 200,000 analytical methods. The company was founded in 2011 and the CEO is Gilles G. Martin. |
Miscellaneous Commercial Services
|
Wiener Neudorf Palmersstraße Real Estate GmbH
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,32% | 84,59 mld. | |
-21,99% | 77,33 mld. | |
+0,99% | 27,12 mld. | |
-5,06% | 18,19 mld. | |
+7,87% | 18,49 mld. | |
+7,69% | 16,49 mld. | |
+76,20% | 13,55 mld. | |
+76,56% | 13,03 mld. | |
-27,72% | 12,43 mld. |